Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
Public ClinicalTrials.gov record NCT01256762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase II Study Of Imetelstat (GRN163L) In Combination With Paclitaxel (With Or Without Bevacizumab) in Patients With Locally Recurrent Or Metastatic Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of treatment with imetelstat + paclitaxel (with or without bevacizumab) versus paclitaxel (with or without bevacizumab) alone for patients with locally recurrent or metastatic breast cancer who have not received chemotherapy or have received one non-taxane based chemotherapy for metastatic breast cancer.
Study identification
- NCT ID
- NCT01256762
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 166 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2010 (Type not available)
- Primary completion
- Oct 2012 (Actual)
- Completion
- Dec 2012 (Actual)
- Last update posted
- Jan 26, 2016
2010 – 2012
United States locations
- U.S. sites
- 50
- U.S. states
- 24
- U.S. cities
- 47
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clearview Cancer Center | Huntsville | Alabama | 35805 | — |
| Alta Bates Summit Medical Center | Berkeley | California | 94704 | — |
| Southbay Oncology Hematology Partners | Campbell | California | 95008 | — |
| Cancer Care Associates | Fresno | California | 93720 | — |
| Memorial Miller Hospital | Long Beach | California | 90806 | — |
| St. Joseph Hospital | Orange | California | 92868 | — |
| Desert Regional Comprehensive Cancer Center | Palm Springs | California | 92262 | — |
| UC San Diego | San Diego | California | 92093 | — |
| Redwood Regional Medical Group | Santa Rosa | California | 95403 | — |
| Univ. Colorado at Denver | Aurora | Colorado | 80045 | — |
| Connecticut Oncology & Hematology | Torrington | Connecticut | 06790 | — |
| Medical Oncology Hematology | Waterbury | Connecticut | 06708 | — |
| Florida Oncology Associates | Jacksonville | Florida | 32256 | — |
| Hematology Oncology Associates | Port Saint Lucie | Florida | 34952 | — |
| H. Lee Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Northeast Georgia Cancer Care | Athens | Georgia | 30607 | — |
| Peachtree Hematology Oncology | Atlanta | Georgia | 30318 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Northeast Georgia Medical Center | Gainesville | Georgia | 30501 | — |
| Central Georgia Cancer Care | Macon | Georgia | 31201 | — |
| Summit Cancer Care | Savannah | Georgia | 31405 | — |
| Kootenai Medical Center | Post Falls | Idaho | 83854 | — |
| Ingalls Memorial Hospital | Chicago | Illinois | 60426 | — |
| Rush University | Chicago | Illinois | 60612 | — |
| Mid Illinois Hematology & Oncology | Normal | Illinois | 61761 | — |
| Cancer Treatment Centers of America | Zion | Illinois | 60099 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| Community Hospitals of Indiana | Indianapolis | Indiana | 46268 | — |
| Horizon Oncology Center | Lafayette | Indiana | 47905 | — |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | — |
| Montgomery Cancer Care | Mount Sterling | Kentucky | 40353 | — |
| Michigan State University | East Lansing | Michigan | 48823 | — |
| New Mexico Cancer Center | Albuquerque | New Mexico | 87109 | — |
| Prohealth Associates | Lake Success | New York | 11402 | — |
| Stony Brook University | Stony Brook | New York | 11794 | — |
| Carolinas Hematology/Oncology | Charlotte | North Carolina | 28203 | — |
| Moses Cone Medical System | Greensboro | North Carolina | 27403 | — |
| Case Western Reserve Univ. | Cleveland | Ohio | 44106 | — |
| Mercy Physicians of Oklahoma | Oklahoma City | Oklahoma | 73120 | — |
| Cancer Care Associates | Tulsa | Oklahoma | 74136 | — |
| Kaiser Northwest | Portland | Oregon | 97232 | — |
| Pinnacle Health | Harrisburg | Pennsylvania | 17110 | — |
| Penn. State Univ. | Hershey | Pennsylvania | 17033 | — |
| The Jones Clinic | Germantown | Tennessee | 38138 | — |
| The West Clinic | Memphis | Tennessee | 38120 | — |
| Scott & White Healthcare | Temple | Texas | 76508 | — |
| Northern Utah Associates | Ogden | Utah | 84403 | — |
| Peninsula Cancer Institute | Newport News | Virginia | 23601 | — |
| Medical Oncology Associates | Spokane | Washington | 99208 | — |
| Northwest Medical Specialties | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01256762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 26, 2016 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01256762 live on ClinicalTrials.gov.